Kraj: Stany Zjednoczone
Język: angielski
Źródło: NLM (National Library of Medicine)
PENTAZOCINE HYDROCHLORIDE (UNII: A36BXO4PPX) (PENTAZOCINE - UNII:RP4A60D26L), NALOXONE HYDROCHLORIDE (UNII: F850569PQR) (NALOXONE - UNII:36B82AMQ7N)
Keltman Pharmaceuticals Inc.
PENTAZOCINE HYDROCHLORIDE
PENTAZOCINE HYDROCHLORIDE 50 mg
ORAL
PRESCRIPTION DRUG
Pentazocine and naloxone hydrochlorides tablets are indicated for the relief of moderate to severe pain. Pentazocine and naloxone hydrochlorides tablets are indicated for oral use only. Pentazocine and naloxone hydrochlorides tablets should not be administered to patients who are hypersensitive to either pentazocine or naloxone. Controlled Substance. Pentazocine and naloxone hydrochlorides tablets are a Schedule IV controlled substance. There have been some reports of dependence and of withdrawal symptoms with orally administered pentazocine. Patients with a history of drug dependence should be under close supervision while receiving pentazocine orally. There have been rare reports of possible abstinence syndromes in newborns after prolonged use of pentazocine during pregnancy. There have been instances of psychological and physical dependence on parenteral pentazocine in patients with a history of drug abuse and rarely, in patients without such a history. Abrupt discontinuance following the extended use of
Pentazocine and Naloxone Hydrochlorides Tablets USP are light green, scored, capsule shaped tablets debossed 395 to the left of the score, 50 over 0.5 to the right of the score and WATSON on the reverse side. They are supplied by Keltman Pharmaceuticals Inc. as follows: Store at controlled room temperature 15°-30°C (59°-86°F). [See USP.] Dispense in a tight, light-resistant container as defined in the USP. Watson Laboratories, Inc. Corona, CA 92880 USA This Product was Repackaged By Sandhills Packaging For: Keltman Pharmaceuticals Inc. 1 Lakeland Square, Suite A Flowood, MS 39232 United States
Abbreviated New Drug Application
PENTAZOCINE AND NALOXONE - PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE TABLET KELTMAN PHARMACEUTICALS INC. ---------- PENTAZOCINE AND NALOXONE HYDROCHLORIDES TABLETS USP RX ONLY SPL UNCLASSIFIED SECTION ANALGESIC FOR ORAL USE ONLY Pentazocine and naloxone hydrochlorides tablets are intended for oral use only. Severe, potentially lethal, reactions may result from misuse of pentazocine and naloxone hydrochlorides tablets by injection either alone or in combination with other substances. (See DRUG ABUSE AND DEPENDENCE section.) DESCRIPTION Pentazocine and naloxone hydrochlorides tablets USP contain pentazocine hydrochloride USP, equivalent to 50 mg base, a member of the benzazocine series (also known as the benzomorphan series), and naloxone hydrochloride USP, equivalent to 0.5 mg base. Pentazocine and naloxone hydrochlorides tablets are an analgesic for oral administration. Chemically, pentazocine hydrochloride is (2_R_*, 6_R_*, 11_R_*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3- methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol hydrochloride, a white, crystalline substance soluble in acidic aqueous solutions. It has the following structural formula: C H NO•HCI MOLECULAR WEIG HT 321.88 Chemically, naloxone hydrochloride is 17-AIlyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride. It is a slightly off-white powder, and is soluble in water and dilute acids. It has the following structural formula: 19 27 C H N0 •HCI MOLECULAR WEIG HT 363.84 Each tablet, for oral administration, contains pentazocine hydrochloride USP, equivalent to 50 mg of pentazocine, and naloxone hydrochloride USP, equivalent to 0.5 mg of naloxone. In addition each tablet contains the following inactive ingredients: colloidal silicon dioxide, dibasic calcium phosphate, D&C Yellow No. 10 Al-lake, FD&C Blue No. 1 Al-lake, FD&C Yellow No. 6 Al-lake, magnesium stearate, microcrystalline cellulose, pregelatinized starch, and sodium lauryl sulfate. CLINICAL PHARMACOLOGY Pentazocine is a potent analgesic which when administered orally in a Przeczytaj cały dokument